Published in BMJ on September 05, 1998
Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? J Infect Dis (2008) 7.76
Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis (2011) 3.54
Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ (2000) 3.10
Antibiotic prescribing for acute cough: the effect of perceived patient demand. Br J Gen Pract (2006) 2.49
Management of urinary tract infection in general practice: a cost-effectiveness analysis. Br J Gen Pract (2000) 2.34
Is 'shared decision-making' feasible in consultations for upper respiratory tract infections? Assessing the influence of antibiotic expectations using discourse analysis. Health Expect (1999) 2.34
Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices. Br J Gen Pract (2007) 2.14
Three-dimensional structure of the bacterial multidrug transporter EmrE shows it is an asymmetric homodimer. EMBO J (2003) 1.90
Seasonal variation in penicillin use in Mexico and Brazil: analysis of the impact of over-the-counter restrictions. Antimicrob Agents Chemother (2014) 1.72
Antibiotic prescribing practices by dentists: a review. Ther Clin Risk Manag (2010) 1.57
Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study. BMJ (2001) 1.50
Trends in antibiotic use among outpatients in New Delhi, India. BMC Infect Dis (2011) 1.49
Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis. Crit Care (2010) 1.45
Antimicrobial drug use in Austrian pig farms: plausibility check of electronic on-farm records and estimation of consumption. Vet Rec (2014) 1.39
GPs' views in five European countries of interventions to promote prudent antibiotic use. Br J Gen Pract (2011) 1.37
A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int (2014) 1.35
Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Rev (2003) 1.33
Antibiotics for coughing in general practice: a questionnaire study to quantify and condense the reasons for prescribing. BMC Fam Pract (2002) 1.27
Controversies in management: should general practitioners perform diagnostic tests on patients before prescribing antibiotics? BMJ (1999) 1.20
Supporting the improvement and management of prescribing for urinary tract infections (SIMPle): protocol for a cluster randomized trial. Trials (2013) 1.19
Cost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults. J Gen Intern Med (2014) 1.17
Rationalised prescribing for community acquired pneumonia: a closed loop audit. Arch Dis Child (2000) 1.14
Does a joint development and dissemination of multidisciplinary guidelines improve prescribing behaviour: a pre/post study with concurrent control group and a randomised trial. BMC Health Serv Res (2006) 1.06
Respiratory tract infections in general practice: considerable differences in prescribing habits between general practitioners in Denmark and Spain. Eur J Clin Pharmacol (2003) 1.05
Antimicrobial activity against gram negative bacilli from Yaounde Central Hospital, Cameroon. Afr Health Sci (2006) 1.03
Stemming the Tide of Antibiotic Resistance (STAR): a protocol for a trial of a complex intervention addressing the 'why' and 'how' of appropriate antibiotic prescribing in general practice. BMC Fam Pract (2009) 0.99
The determinants of the antibiotic resistance process. Infect Drug Resist (2009) 0.98
Maggots are useful in treating infected or necrotic wounds. BMJ (1999) 0.98
Molecular characterisation of trimethoprim resistance in Escherichia coli and Klebsiella pneumoniae during a two year intervention on trimethoprim use. PLoS One (2010) 0.98
Enhancing the quality of antibiotic prescribing in primary care: qualitative evaluation of a blended learning intervention. BMC Fam Pract (2010) 0.97
Comparison of lysis filtration and an automated blood culture system (BACTEC) for detection, quantification, and identification of odontogenic bacteremia in children. J Clin Microbiol (2002) 0.95
National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents. J Clin Pathol (2003) 0.93
Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009-2013). Eur J Clin Microbiol Infect Dis (2014) 0.91
Implications of stress-induced genetic variation for minimizing multidrug resistance in bacteria. BMC Med (2012) 0.91
Enabling factors for antibiotic prescribing for upper respiratory tract infections: perspectives of Lithuanian and Russian general practitioners. Ups J Med Sci (2013) 0.91
Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli. Antimicrob Agents Chemother (2005) 0.90
Over-the-counter suboptimal dispensing of antibiotics in Uganda. J Multidiscip Healthc (2013) 0.89
Health-Promoting Properties of Lactobacillus helveticus. Front Microbiol (2012) 0.88
Prophylactic antibiotics to prevent urinary tract infection during clean intermittent self-catheterization (CISC) for management of voiding dysfunction after prolapse and incontinence surgery: a decision analysis. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.86
In vitro evaluation of a new treatment for urinary tract infections caused by nitrate-reducing bacteria. Antimicrob Agents Chemother (2003) 0.86
Otitis media with effusion in children. BMJ Clin Evid (2011) 0.86
Using qualitative insights to change practice: exploring the culture of antibiotic prescribing and consumption for urinary tract infections. BMJ Open (2016) 0.85
Antibiotic resistance in bacteria - an emerging public health problem. Malawi Med J (2003) 0.84
DNA microarray analysis reveals that antibiotic resistance-gene diversity in human gut microbiota is age related. Sci Rep (2014) 0.83
Improving antibiotic prescribing for children in the resource-poor setting. Br J Clin Pharmacol (2015) 0.83
Acquired immunoparalysis in paediatric intensive care: prospective observational study. BMJ (1999) 0.82
Excretion of beta-lactam antibiotics in sweat--a neglected mechanism for development of antibiotic resistance? Antimicrob Agents Chemother (2000) 0.80
The relationship among antibiotic consumption, socioeconomic factors and climatic conditions. Can J Infect Dis Med Microbiol (2010) 0.80
Knowledge of antibiotics among dentists in Riyadh private clinics. Saudi Dent J (2013) 0.80
Antibiotic prescribing of village doctors for children under 15 years with upper respiratory tract infections in rural China: A qualitative study. Medicine (Baltimore) (2016) 0.79
Antimicrobial mechanisms behind photodynamic effect in the presence of hydrogen peroxide. Photochem Photobiol Sci (2010) 0.79
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study. BMC Infect Dis (2014) 0.78
Burns (minor thermal). BMJ Clin Evid (2009) 0.78
Recovery of cephalosporin-resistant Escherichia coli and Salmonella from pork, beef and chicken marketed in Nova Scotia. Can J Infect Dis Med Microbiol (2004) 0.78
Antibiotic resistance: the Bermuda experience. J Clin Microbiol (1999) 0.78
Exploratory Spatial Mapping of the Occurrence of Antimicrobial Resistance in E. coli in the Community. Antibiotics (Basel) (2013) 0.77
Pattern of Antibiotic Resistance Among Community Derived Isolates of Enterobacteriaceae Using Urine Sample: A Study From Northern India. J Clin Diagn Res (2015) 0.77
Physicians' attitudes and knowledge concerning antibiotic prescription and resistance: questionnaire development and reliability. BMC Infect Dis (2016) 0.77
Performance of thirteen clinical rules to distinguish bacterial and presumed viral meningitis in Vietnamese children. PLoS One (2012) 0.77
Knowledge, attitudes and practices towards antibiotic use in upper respiratory tract infections among patients seeking primary health care in Singapore. BMC Fam Pract (2016) 0.77
Antibiotic prescribing and resistance: knowledge level of medical students of clinical years of University Sultan Zainal Abidin, Malaysia. Ther Clin Risk Manag (2016) 0.77
Otitis media with effusion in children. BMJ Clin Evid (2007) 0.76
Occurrence and distribution of antibiotic-resistant bacteria and transfer of resistance genes in Lake Taihu. Microbes Environ (2013) 0.76
Antibiotic Use in Children with Acute Respiratory or Ear Infections: Prospective Observational Comparison of Anthroposophic and Conventional Treatment under Routine Primary Care Conditions. Evid Based Complement Alternat Med (2014) 0.75
Evaluation of fecal microorganisms of children with cleft palate before and after palatoplasty. Braz J Microbiol (2014) 0.75
Use of antibiotics in animal agriculture & emergence of methicillin-resistant Staphylococcus aureus (MRSA) clones: need to assess the impact on public health. Indian J Med Res (2014) 0.75
Contributors to antibiotic resistance. Antibiotics should not be first treatment for acne. BMJ (1999) 0.75
How Often Are Antibiotic-Resistant Bacteria Said to "Evolve" in the News? PLoS One (2016) 0.75
The hidden societal cost of antibiotic resistance per antibiotic prescribed in the United States: an exploratory analysis. BMC Infect Dis (2016) 0.75
The effectiveness of the McIsaac clinical decision rule in the management of sore throat: an evaluation from a pediatrics ward. Pediatr Res (2016) 0.75
Bronchitis (acute). BMJ Clin Evid (2011) 0.75
Metagenomic analysis of planktonic microbial consortia from a non-tidal urban-impacted segment of James River. Stand Genomic Sci (2015) 0.75
Antibiotic Use in Sore Throat: Are We Judicious? Indian J Otolaryngol Head Neck Surg (2015) 0.75
Antibiotic prescribing in various clinical departments in a tertiary care teaching hospital in northern India. J Clin Diagn Res (2014) 0.75
Antibiotic Self-Prescribing Trends, Experiences and Attitudes in Upper Respiratory Tract Infection among Pharmacy and Non-Pharmacy Students: A Study from Lahore. PLoS One (2016) 0.75
New-variant Creutzfeldt-Jacob disease. Br J Gen Pract (2000) 0.75
Improving antimicrobial prescribing in Irish primary care through electronic data collection and surveillance: a feasibility study. BMC Fam Pract (2015) 0.75
Synthesis Characterization and Antibacterial, Antifungal Activity of N-(Benzyl Carbamoyl or Carbamothioyl)-2-hydroxy Substituted Benzamide and 2-Benzyl Amino-Substituted Benzoxazines. Int J Med Chem (2013) 0.75
Three years of antibacterial consumption in Indonesian Community Health Centers: The application of anatomical therapeutic chemical/defined daily doses and drug utilization 90% method to monitor antibacterial use. J Family Community Med (2015) 0.75
Bronchitis (acute). BMJ Clin Evid (2008) 0.75
Bronchitis (acute). BMJ Clin Evid (2015) 0.75
Modeling antibiotic treatment in hospitals: A systematic approach shows benefits of combination therapy over cycling, mixing, and mono-drug therapies. PLoS Comput Biol (2017) 0.75
The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (1997) 4.81
Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis (1997) 3.91
Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. JAMA (1997) 2.62
Local surveillance of antimicrobial resistance. Synercid Resistance Surveillance Group. Lancet (1998) 2.60
The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally. Clin Infect Dis (1997) 2.05
Molecular epidemiology of drug-resistant pneumococci: toward an international approach. Microb Drug Resist (1997) 2.03
New strategies for antibacterial drug design. Trends Microbiol (1997) 1.35
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrob Agents Chemother (1983) 21.48
The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med (1997) 9.63
Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Agents Chemother (1983) 8.82
The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics. J Infect Dis (1980) 8.40
Evolutionary genetic relationships of clones of Salmonella serovars that cause human typhoid and other enteric fevers. Infect Immun (1990) 6.42
Variation in antibiotic use in the European Union. Lancet (2001) 6.02
Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother (1993) 4.83
HR 756, a highly active cephalosporin: comparison with cefazolin and carbenicillin. Antimicrob Agents Chemother (1978) 4.74
LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics. Antimicrob Agents Chemother (1979) 4.52
Toward a population genetic analysis of Salmonella: genetic diversity and relationships among strains of serotypes S. choleraesuis, S. derby, S. dublin, S. enteritidis, S. heidelberg, S. infantis, S. newport, and S. typhimurium. Proc Natl Acad Sci U S A (1988) 4.43
Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J (Clin Res Ed) (1986) 4.16
The pharmacokinetics and tissue penetration of ofloxacin. J Antimicrob Chemother (1984) 4.15
Functional anatomy of a common semantic system for words and pictures. Nature (1996) 4.14
Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin. Antimicrob Agents Chemother (1980) 4.07
A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother (1998) 3.97
Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins. Antimicrob Agents Chemother (1978) 3.68
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother (2009) 3.62
Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 3.58
Epidemiology of virulence-associated plasmids and outer membrane protein patterns within seven common Salmonella serotypes. Infect Immun (1985) 3.51
The anatomy of phonological and semantic processing in normal subjects. Brain (1992) 3.41
Rapid diagnosis of Campylobacter-associated gastritis. Lancet (1985) 3.38
In vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrob Agents Chemother (1997) 3.22
Association of Helicobacter pylori infection with coronary heart disease. Study shows association between H pylori infection and hypertension. BMJ (1996) 3.00
Mupirocin resistance. Lancet (1991) 2.88
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother (1985) 2.85
Pharmacokinetics of intravenously administered ciprofloxacin. Antimicrob Agents Chemother (1984) 2.83
Pharmacokinetics and tissue penetration of enoxacin. Antimicrob Agents Chemother (1984) 2.79
Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. Antimicrob Agents Chemother (1999) 2.73
Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci (2001) 2.68
Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother (1999) 2.64
Local surveillance of antimicrobial resistance. Synercid Resistance Surveillance Group. Lancet (1998) 2.60
Detection and characterization of fecal verotoxin-producing Escherichia coli from healthy cattle. J Clin Microbiol (1990) 2.60
In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin. Antimicrob Agents Chemother (1978) 2.58
Reward circuitry activation by noxious thermal stimuli. Neuron (2001) 2.56
Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds. Antimicrob Agents Chemother (1980) 2.51
The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents. J Antimicrob Chemother (1995) 2.49
Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime. Antimicrob Agents Chemother (1981) 2.48
In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites. Antimicrob Agents Chemother (1986) 2.45
Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints. J Antimicrob Chemother (1998) 2.42
MRI in schistosomiasis of conus medullaris and lumbar spinal cord. Lancet (1993) 2.40
Mycobacterium chelonei isolation from broncho-alveolar lavage fluid and its practical implications. J Hosp Infect (1990) 2.37
A reassessment of the in-vitro activity of colistin sulphomethate sodium. J Antimicrob Chemother (1997) 2.37
Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins. J Antimicrob Chemother (1980) 2.35
Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob Agents Chemother (1998) 2.33
Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol (1999) 2.33
Azithromycin concentrations at the sites of pulmonary infection. Eur Respir J (1990) 2.33
Assignment of tra cistrons to EcoRI fragments of F sex factor DNA. J Bacteriol (1978) 2.32
Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum (1999) 2.22
Prevalence and clinical correlates of bronchoreversibility in severe emphysema. Eur Respir J (2009) 2.18
Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis (2008) 2.17
Cloning of enterotoxin gene from Aeromonas hydrophila provides conclusive evidence of production of a cytotonic enterotoxin. Infect Immun (1984) 2.16
The pharmacokinetics and tissue penetration of norfloxacin. J Antimicrob Chemother (1984) 2.15
Operon structure of DNA transfer cistrons on the F sex factor. Nature (1975) 2.15
Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin. Antimicrob Agents Chemother (1992) 2.14
Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration. Antimicrob Agents Chemother (1982) 2.12
Early and late weight gain following smoking cessation in the Lung Health Study. Am J Epidemiol (1998) 2.10
In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent. J Antimicrob Chemother (1990) 2.09
Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs. Antimicrob Agents Chemother (1978) 2.07
In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents. Antimicrob Agents Chemother (1986) 2.04
In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents. J Antimicrob Chemother (1984) 2.01
Prophylactic use of cephazolin against wound sepsis after cholecystectomy. Br Med J (1977) 1.97
Reproducibility of random amplified polymorphic DNA (RAPD) analysis among laboratories. PCR Methods Appl (1993) 1.97
Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic. Chemotherapy (1974) 1.97
Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone. Antimicrob Agents Chemother (1987) 1.96
Commercially available fluorescein-conjugated monoclonal antibody for determining the in vitro activity of antimicrobial agents against Chlamydia trachomatis. Eur J Clin Microbiol (1987) 1.93
Rapid diagnosis of Campylobacter pyloridis gastritis. Lancet (1986) 1.92
The cortical localization of the lexicons. Positron emission tomography evidence. Brain (1992) 1.91
Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro. Antimicrob Agents Chemother (1991) 1.88
Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins. Antimicrob Agents Chemother (1980) 1.87
The comparative pharmacokinetics of five quinolones. J Antimicrob Chemother (1986) 1.86
Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions. J Antimicrob Chemother (1991) 1.85
Use of antibiotics. Penicillins. Br Med J (1978) 1.85
Pharmacokinetics and tissue penetration of orally administered lomefloxacin. Antimicrob Agents Chemother (1988) 1.85
The pharmacokinetics of LY127935, a broad spectrum oxa-beta-lactam. J Antimicrob Chemother (1980) 1.85
Pharmacokinetics and tissue penetration of linezolid following multiple oral doses. Antimicrob Agents Chemother (2001) 1.84
Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob Agents Chemother (1992) 1.84
katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob Agents Chemother (1996) 1.82
Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance. Antimicrob Agents Chemother (1992) 1.80
Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection. J Antimicrob Chemother (2003) 1.80
Ceftazidime--a new extended-spectrum cephalosporin. Lancet (1982) 1.79
Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis (2001) 1.78
Evaluation of methods for epidemiologic typing of group A streptococci. J Infect Dis (1994) 1.75
The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin. J Antimicrob Chemother (1989) 1.75
Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels. Antimicrob Agents Chemother (1980) 1.75
Bacteroides fragilis and HR 756. J Antimicrob Chemother (1979) 1.73
Temocillin, in-vitro activity and the pharmacokinetics and tissue penetration in healthy volunteers. J Antimicrob Chemother (1982) 1.70
Ro 13-9904: A cephalosporin with a high degree of activity and broad antibacterial activity: an invitro comparative study. J Antimicrob Chemother (1980) 1.68
The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po. J Antimicrob Chemother (1994) 1.68
Chlamydia pneumoniae and asthma. Thorax (1998) 1.67
Causes of the haemolytic uraemic syndrome. BMJ (1989) 1.66
The structural components of music perception. A functional anatomical study. Brain (1997) 1.66
Functional analysis of a light-responsive plant bZIP transcriptional regulator. Plant Cell (1994) 1.66
The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clin Pharmacokinet (1987) 1.66
N-formimidoyl-thienamycin a novel beta-lactam: an in-vitro comparison with other beta-lactam antibiotics. J Antimicrob Chemother (1981) 1.65
Outbreak of diarrhoea due to Escherichia coli O111:B4 in schoolchildren and adults: association of Vi antigen-like reactivity. Lancet (1990) 1.65
The effect of reserpine, an inhibitor of multi-drug efflux pumps, on the in-vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacin. J Antimicrob Chemother (1997) 1.63
Typing of group A streptococci by random amplified polymorphic DNA analysis. J Clin Microbiol (1994) 1.63
Cell-autonomous expression of barley Mla1 confers race-specific resistance to the powdery mildew fungus via a Rar1-independent signaling pathway. Plant Cell (2001) 1.62
Pharmacokinetics and inflammatory fluid penetration of sparfloxacin. Antimicrob Agents Chemother (1992) 1.62
Evaluation of a genus-specific monoclonal antibody in an amplified enzyme-linked immunoassay in the detection of Chlamydia in urine samples from men. Sex Transm Dis (1990) 1.60